Insufficient scRNA-seq data for expression of AS3MT at single-cell level.
Insufficient scRNA-seq data for expression of AS3MT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 2239.48 | 226 / 226 | 0% | 0.00 | 1 / 406 |
| adrenal gland | 100% | 30635.49 | 258 / 258 | 0% | 0 | 0 / 230 |
| kidney | 100% | 981.40 | 89 / 89 | 0% | 0 | 0 / 901 |
| ovary | 100% | 912.56 | 180 / 180 | 0% | 0 | 0 / 430 |
| pancreas | 100% | 702.56 | 328 / 328 | 0% | 0 | 0 / 178 |
| prostate | 100% | 912.24 | 245 / 245 | 0% | 0 | 0 / 502 |
| spleen | 100% | 2035.75 | 241 / 241 | 0% | 0 | 0 / 0 |
| thymus | 100% | 878.60 | 653 / 653 | 0% | 0 | 0 / 605 |
| uterus | 100% | 780.74 | 170 / 170 | 0% | 0 | 0 / 459 |
| brain | 99% | 814.04 | 2627 / 2642 | 0% | 0 | 0 / 705 |
| heart | 99% | 1716.88 | 852 / 861 | 0% | 0 | 0 / 0 |
| skin | 96% | 432.07 | 1744 / 1809 | 0% | 0 | 0 / 472 |
| lung | 96% | 402.66 | 555 / 578 | 0% | 0 | 0 / 1155 |
| blood vessel | 95% | 453.75 | 1270 / 1335 | 0% | 0 | 0 / 0 |
| breast | 94% | 487.40 | 432 / 459 | 0% | 0 | 0 / 1118 |
| muscle | 94% | 507.67 | 754 / 803 | 0% | 0 | 0 / 0 |
| esophagus | 93% | 607.34 | 1341 / 1445 | 1% | 0.01 | 1 / 183 |
| stomach | 93% | 413.05 | 334 / 359 | 0% | 0 | 0 / 286 |
| intestine | 93% | 518.74 | 895 / 966 | 0% | 0 | 0 / 527 |
| adipose | 90% | 365.55 | 1083 / 1204 | 0% | 0 | 0 / 0 |
| bladder | 86% | 353.67 | 18 / 21 | 0% | 0 | 0 / 504 |
| peripheral blood | 18% | 52.30 | 167 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0009404 | Biological process | toxin metabolic process |
| GO_0018872 | Biological process | arsonoacetate metabolic process |
| GO_0032259 | Biological process | methylation |
| GO_0005829 | Cellular component | cytosol |
| GO_0030791 | Molecular function | arsenite methyltransferase activity |
| Gene name | AS3MT |
| Protein name | Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase) |
| Synonyms | CYT19 |
| Description | FUNCTION: Catalyzes the transfer of a methyl group from AdoMet to trivalent arsenicals producing methylated and dimethylated arsenicals . It methylates arsenite to form methylarsonate, Me-AsO(3)H(2), which is reduced by methylarsonate reductase to methylarsonite, Me-As(OH)2 . Methylarsonite is also a substrate and it is converted into the much less toxic compound dimethylarsinate (cacodylate), Me(2)As(O)-OH . . |
| Accessions | Q9HBK9 ENST00000369880.8 [Q9HBK9-1] |